Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease
Matthew A. Odenwald, Huaiying Lin, Christopher Lehmann, Nicholas P. Dylla, Cody G. Cole, Jake D. Mostad, Téa E. Pappas, Ramanujam Ramaswamy, Angelica Moran, Alan L. Hutchison, M.R. Stutz, Mark Dela Cruz, Emerald Adler, Jaye Boissiere, Maryam Khalid, Jackelyn Cantoral, Fidel Haro, Rita A. Oliveira, Emily Waligurski, Thomas G. Cotter, S.H. Light, Kathleen G. Beavis, Anitha Sundararajan, Ashley M. Sidebottom, K. Gautham Reddy, Sonali Paul, Anjana Pillai, Helen S. Te, Mary E. Rinella, Michael Charlton, Eric G. Pamer, Andrew Aronsohn
Topics & Concepts
LactuloseHepatic encephalopathyMicrobiomePrebioticRifaximinLiver diseaseBiologyAntibioticsGut floraGastroenterologyInflammatory bowel diseaseMicrobiologyChronic liver diseaseInternal medicineMedicineCirrhosisDiseaseImmunologyBioinformaticsBiochemistryLiver Disease Diagnosis and TreatmentGut microbiota and healthLiver Disease and Transplantation